Circulating tumor cells: silent predictors of metastasis [version 1; referees: 2 approved]

by LanLan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El-Deiry, R. Katherine Alpaugh
Published 2017-08-01

P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9

by Xiaobing Tian, Nagib Ahsan, Amriti Lulla, Avital Lev, Philip Abbosh, David T. Dicker, Shengliang Zhang, Wafik S. El-Deiry
Published 2021-03-01

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer

by Joshua E. Allen, Jean-Nicolas Gallant, David T. Dicker, Shantu Amin, Rosalyn B. Irby, Arun K. Sharma, Wafik S. El-Deiry
Published 2013-01-01

The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.

by Joshua E Allen, Jean-Nicolas Gallant, David T Dicker, Shantu Amin, Rosalyn B Irby, Arun K Sharma, Wafik S El-Deiry
Published 2013-01-01

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer.

by Joshua E. Allen, Jean-Nicolas Gallant, David T. Dicker, Shantu Amin, Rosalyn B. Irby, Arun K. Sharma, Wafik S. El-Deiry
Published 2013-01-01

A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53

by Liz Hernandez Borrero, David T Dicker, John Santiago, Jennifer Sanders, Xiaobing Tian, Nagib Ahsan, Avital Lev, Lanlan Zhou, Wafik S El-Deiry
Published 2021-07-01

Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.

by Junaid Abdulghani, Joshua E Allen, David T Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D Smith, Robin Humphreys, Wafik S El-Deiry
Published 2013-01-01

Role of Dopamine Receptors in the Anticancer Activity of ONC201

by Christina Leah B. Kline, Marie D. Ralff, Amriti R. Lulla, Jessica M. Wagner, Phillip H. Abbosh, David T. Dicker, Joshua E. Allen, Wafik S. El-Deiry
Published 2018-01-01